Cellular Tumor Antigen p53 Market Report

Global and Region Cellular Tumor Antigen p53 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：136
  • REPORT CODE：GMM910504
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cellular Tumor Antigen p53 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cellular Tumor Antigen p53market, defines the market attractiveness level of Cellular Tumor Antigen p53 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cellular Tumor Antigen p53 industry, describes the types of Cellular Tumor Antigen p53 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cellular Tumor Antigen p53 market and the development prospects and opportunities of Cellular Tumor Antigen p53 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cellular Tumor Antigen p53 market in Chapter 13.

    By Player:

    • Critical Outcome Technologies Inc

    • OSE Pharma SA

    • American Gene Technologies International Inc

    • Eleos Inc

    • SK Biopharmaceuticals Co, Ltd

    • Tara Immuno-Oncology Therapeutics LLC

    • Shenzen SiBiono GeneTech Co, Ltd

    • Stemline Therapeutics, Inc

    • Z53 Therapeutics, LLC

    • Advaxis, Inc

    • Cellceutix Corporation

    • Aprea AB

    • Quark Pharmaceuticals, Inc

    • PCI Biotech Holding ASA

    • ORCA Therapeutics BV

    By Type:

    • COTI-2

    • D-12PGJ3

    • APR-246

    • ATRN-502

    • Cenersen Sodium

    • MJ-05

    • MX-225

    • Others

    By End-User:

    • Ovarian Cancer

    • Prostate Cancer

    • Brain Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cellular Tumor Antigen p53 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cellular Tumor Antigen p53 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cellular Tumor Antigen p53 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cellular Tumor Antigen p53 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cellular Tumor Antigen p53 Market Analysis and Outlook to 2022

    • 7.1 Global Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.2 United States Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.3 Europe Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.4 China Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.5 Japan Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.6 India Cellular Tumor Antigen p53 Consumption (2017-2022)

    • 7.7 South Korea Cellular Tumor Antigen p53 Consumption (2017-2022)

    8 Region and Country-wise Cellular Tumor Antigen p53 Market Analysis and Outlook to 2028

    • 8.1 Global Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.2 United States Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.3 Europe Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.4 China Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.5 Japan Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.6 India Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    • 8.7 South Korea Cellular Tumor Antigen p53 Consumption Forecast (2022-2028)

    9 Global Cellular Tumor Antigen p53 Market Outlook by Types and Applications to 2022

    • 9.1 Global Cellular Tumor Antigen p53 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global COTI-2 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global D-12PGJ3 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global APR-246 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ATRN-502 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Cenersen Sodium Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MJ-05 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global MX-225 Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cellular Tumor Antigen p53 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Brain Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cellular Tumor Antigen p53 Market Outlook by Types and Applications to 2028

    • 10.1 Global Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global COTI-2 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global D-12PGJ3 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global APR-246 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ATRN-502 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Cenersen Sodium Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global MJ-05 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global MX-225 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cellular Tumor Antigen p53 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cellular Tumor Antigen p53 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cellular Tumor Antigen p53 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cellular Tumor Antigen p53 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cellular Tumor Antigen p53 Market Competitive Analysis

    • 14.1 Critical Outcome Technologies Inc

      • 14.1.1 Critical Outcome Technologies Inc Company Details

      • 14.1.2 Critical Outcome Technologies Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Critical Outcome Technologies Inc Cellular Tumor Antigen p53 Product and Service

    • 14.2 OSE Pharma SA

      • 14.2.1 OSE Pharma SA Company Details

      • 14.2.2 OSE Pharma SA Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 OSE Pharma SA Cellular Tumor Antigen p53 Product and Service

    • 14.3 American Gene Technologies International Inc

      • 14.3.1 American Gene Technologies International Inc Company Details

      • 14.3.2 American Gene Technologies International Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 American Gene Technologies International Inc Cellular Tumor Antigen p53 Product and Service

    • 14.4 Eleos Inc

      • 14.4.1 Eleos Inc Company Details

      • 14.4.2 Eleos Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eleos Inc Cellular Tumor Antigen p53 Product and Service

    • 14.5 SK Biopharmaceuticals Co, Ltd

      • 14.5.1 SK Biopharmaceuticals Co, Ltd Company Details

      • 14.5.2 SK Biopharmaceuticals Co, Ltd Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 SK Biopharmaceuticals Co, Ltd Cellular Tumor Antigen p53 Product and Service

    • 14.6 Tara Immuno-Oncology Therapeutics LLC

      • 14.6.1 Tara Immuno-Oncology Therapeutics LLC Company Details

      • 14.6.2 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product and Service

    • 14.7 Shenzen SiBiono GeneTech Co, Ltd

      • 14.7.1 Shenzen SiBiono GeneTech Co, Ltd Company Details

      • 14.7.2 Shenzen SiBiono GeneTech Co, Ltd Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Shenzen SiBiono GeneTech Co, Ltd Cellular Tumor Antigen p53 Product and Service

    • 14.8 Stemline Therapeutics, Inc

      • 14.8.1 Stemline Therapeutics, Inc Company Details

      • 14.8.2 Stemline Therapeutics, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Stemline Therapeutics, Inc Cellular Tumor Antigen p53 Product and Service

    • 14.9 Z53 Therapeutics, LLC

      • 14.9.1 Z53 Therapeutics, LLC Company Details

      • 14.9.2 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product and Service

    • 14.10 Advaxis, Inc

      • 14.10.1 Advaxis, Inc Company Details

      • 14.10.2 Advaxis, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Advaxis, Inc Cellular Tumor Antigen p53 Product and Service

    • 14.11 Cellceutix Corporation

      • 14.11.1 Cellceutix Corporation Company Details

      • 14.11.2 Cellceutix Corporation Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Cellceutix Corporation Cellular Tumor Antigen p53 Product and Service

    • 14.12 Aprea AB

      • 14.12.1 Aprea AB Company Details

      • 14.12.2 Aprea AB Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Aprea AB Cellular Tumor Antigen p53 Product and Service

    • 14.13 Quark Pharmaceuticals, Inc

      • 14.13.1 Quark Pharmaceuticals, Inc Company Details

      • 14.13.2 Quark Pharmaceuticals, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Quark Pharmaceuticals, Inc Cellular Tumor Antigen p53 Product and Service

    • 14.14 PCI Biotech Holding ASA

      • 14.14.1 PCI Biotech Holding ASA Company Details

      • 14.14.2 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product and Service

    • 14.15 ORCA Therapeutics BV

      • 14.15.1 ORCA Therapeutics BV Company Details

      • 14.15.2 ORCA Therapeutics BV Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 ORCA Therapeutics BV Cellular Tumor Antigen p53 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cellular Tumor Antigen p53

    • Figure Cellular Tumor Antigen p53 Picture

    • Table Global Cellular Tumor Antigen p53 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cellular Tumor Antigen p53 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cellular Tumor Antigen p53 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cellular Tumor Antigen p53 Consumption by Country (2017-2022)

    • Figure United States Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Table Europe Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Figure China Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Figure Japan Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Figure India Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cellular Tumor Antigen p53 Consumption and Growth Rate (2017-2022)

    • Figure Global Cellular Tumor Antigen p53 Consumption Forecast by Country (2022-2028)

    • Figure United States Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cellular Tumor Antigen p53 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global COTI-2 Consumption and Growth Rate (2017-2022)

    • Figure Global D-12PGJ3 Consumption and Growth Rate (2017-2022)

    • Figure Global APR-246 Consumption and Growth Rate (2017-2022)

    • Figure Global ATRN-502 Consumption and Growth Rate (2017-2022)

    • Figure Global Cenersen Sodium Consumption and Growth Rate (2017-2022)

    • Figure Global MJ-05 Consumption and Growth Rate (2017-2022)

    • Figure Global MX-225 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Ovarian Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global COTI-2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global D-12PGJ3 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global APR-246 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ATRN-502 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cenersen Sodium Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MJ-05 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MX-225 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ovarian Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cellular Tumor Antigen p53 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cellular Tumor Antigen p53 Export by Region (Top 5 Countries) (2017-2028)

    • Table Critical Outcome Technologies Inc (Foundation Year, Company Profile and etc.)

    • Table Critical Outcome Technologies Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Critical Outcome Technologies Inc Cellular Tumor Antigen p53 Product and Service

    • Table OSE Pharma SA (Foundation Year, Company Profile and etc.)

    • Table OSE Pharma SA Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table OSE Pharma SA Cellular Tumor Antigen p53 Product and Service

    • Table American Gene Technologies International Inc (Foundation Year, Company Profile and etc.)

    • Table American Gene Technologies International Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table American Gene Technologies International Inc Cellular Tumor Antigen p53 Product and Service

    • Table Eleos Inc (Foundation Year, Company Profile and etc.)

    • Table Eleos Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eleos Inc Cellular Tumor Antigen p53 Product and Service

    • Table SK Biopharmaceuticals Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table SK Biopharmaceuticals Co, Ltd Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table SK Biopharmaceuticals Co, Ltd Cellular Tumor Antigen p53 Product and Service

    • Table Tara Immuno-Oncology Therapeutics LLC (Foundation Year, Company Profile and etc.)

    • Table Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tara Immuno-Oncology Therapeutics LLC Cellular Tumor Antigen p53 Product and Service

    • Table Shenzen SiBiono GeneTech Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Shenzen SiBiono GeneTech Co, Ltd Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shenzen SiBiono GeneTech Co, Ltd Cellular Tumor Antigen p53 Product and Service

    • Table Stemline Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table Stemline Therapeutics, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stemline Therapeutics, Inc Cellular Tumor Antigen p53 Product and Service

    • Table Z53 Therapeutics, LLC (Foundation Year, Company Profile and etc.)

    • Table Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Z53 Therapeutics, LLC Cellular Tumor Antigen p53 Product and Service

    • Table Advaxis, Inc (Foundation Year, Company Profile and etc.)

    • Table Advaxis, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advaxis, Inc Cellular Tumor Antigen p53 Product and Service

    • Table Cellceutix Corporation (Foundation Year, Company Profile and etc.)

    • Table Cellceutix Corporation Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cellceutix Corporation Cellular Tumor Antigen p53 Product and Service

    • Table Aprea AB (Foundation Year, Company Profile and etc.)

    • Table Aprea AB Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aprea AB Cellular Tumor Antigen p53 Product and Service

    • Table Quark Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Quark Pharmaceuticals, Inc Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quark Pharmaceuticals, Inc Cellular Tumor Antigen p53 Product and Service

    • Table PCI Biotech Holding ASA (Foundation Year, Company Profile and etc.)

    • Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table PCI Biotech Holding ASA Cellular Tumor Antigen p53 Product and Service

    • Table ORCA Therapeutics BV (Foundation Year, Company Profile and etc.)

    • Table ORCA Therapeutics BV Cellular Tumor Antigen p53 Sales, Price, Value and Gross Profit (2017-2022)

    • Table ORCA Therapeutics BV Cellular Tumor Antigen p53 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US